Cargando…

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study

BACKGROUND: Colorectal cancer screening programmes worldwide have been disrupted during the COVID-19 pandemic. We aimed to estimate the impact of hypothetical disruptions to organised faecal immunochemical test-based colorectal cancer screening programmes on short-term and long-term colorectal cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jonge, Lucie, Worthington, Joachim, van Wifferen, Francine, Iragorri, Nicolas, Peterse, Elisabeth F P, Lew, Jie-Bin, Greuter, Marjolein J E, Smith, Heather A, Feletto, Eleonora, Yong, Jean H E, Canfell, Karen, Coupé, Veerle M H, Lansdorp-Vogelaar, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767453/ https://www.ncbi.nlm.nih.gov/pubmed/33548185 http://dx.doi.org/10.1016/S2468-1253(21)00003-0

Ejemplares similares

783 IMPACT OF COVID-19 RELATED DISRUPTIONS TO COLORECTAL CANCER SCREENING PROGRAMS IN THREE COUNTRIES: A COMPARATIVE MODELLING STUDY
por: De Jonge, Lucie, et al.
Publicado: (2021)

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
por: van Wifferen, Francine, et al.
Publicado: (2022)

Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
por: Worthington, Joachim, et al.
Publicado: (2023)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
por: Buskermolen, Maaike, et al.
Publicado: (2019)

Resilience of a FIT screening programme against screening fatigue: a modelling study
por: Greuter, Marjolein J. E., et al.
Publicado: (2016)

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program
por: Vleugels, Jasper L. A., et al.
Publicado: (2017)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study
por: Terhaar sive Droste, Jochim S, et al.
Publicado: (2012)

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
por: van der Meulen, Miriam P., et al.
Publicado: (2022)

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017)

Effect of oral anticoagulants on the outcome of faecal immunochemical test
por: Bujanda, L, et al.
Publicado: (2014)

Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)

Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia
por: Goldsbury, David E., et al.
Publicado: (2021)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
por: van Turenhout, Sietze T, et al.
Publicado: (2014)

Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
por: Barnett, Karen N., et al.
Publicado: (2021)

Accuracy of faecal immunochemical testing in patients with symptomatic colorectal cancer
por: Khan, A. A., et al.
Publicado: (2020)

Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040
por: Luo, Qingwei, et al.
Publicado: (2022)

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic
por: Kortlever, Tim L., et al.
Publicado: (2021)

Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study
por: Oort, Frank A, et al.
Publicado: (2011)

Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment
por: Worthington, Joachim, et al.
Publicado: (2020)

Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening.
por: Castiglione, G., et al.
Publicado: (1992)

Faecal immunochemical testing in the COVID-19 era: balancing risk and costs
por: Arasaradnam, Ramesh P, et al.
Publicado: (2020)

Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
por: Farrugia, Alexia, et al.
Publicado: (2019)

Faecal immunochemical test: challenges and opportunities for cancer diagnosis in primary care
por: Craig, Mary, et al.
Publicado: (2022)

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients
por: Symonds, Erin L., et al.
Publicado: (2022)

Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, A D, et al.
Publicado: (2023)

Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
por: Peterse, Elisabeth F P, et al.
Publicado: (2020)

Faecal immunochemical testing implementation to increase colorectal cancer screening in primary care
por: Bakhai, Smita, et al.
Publicado: (2018)

Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience
por: Remes-Troche, José María, et al.
Publicado: (2020)

Faecal Immunochemical Test Impact on Prognosis of Colorectal Cancer Detected in Symptomatic Patients
por: Fernández de Castro, Jesús Daniel, et al.
Publicado: (2022)

Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care
por: Johnstone, Mark S., et al.
Publicado: (2022)

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
por: Digby, Jayne, et al.
Publicado: (2023)

Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
por: White, P, et al.
Publicado: (2023)

Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Chong, Yuki, et al.
Publicado: (2023)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gth00bn6hq44jgf57aaquddll5